Exact Mass: 454.2267738
Exact Mass Matches: 454.2267738
Found 500 metabolites which its exact mass value is equals to given mass value 454.2267738
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vistamycin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID R016
beta-FNA
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D009676 - Noxae > D000477 - Alkylating Agents
Butyl (S)-3-hydroxybutyrate [arabinosyl-(1->6)-glucoside]
C19H34O12 (454.20501640000003)
Butyl (S)-3-hydroxybutyrate [arabinosyl-(1->6)-glucoside] is found in fruits. Butyl (S)-3-hydroxybutyrate [arabinosyl-(1->6)-glucoside] is isolated from Cape gooseberry (Physalis peruviana).
Methyl cellulose
C20H38O11 (454.24139979999995)
Methyl cellulose is a stabiliser, thickener and emulsifier for foodstuffs Different kinds of methyl cellulose can be prepared depending on the number of hydroxyl groups substituted. Cellulose is a polymer consisting of numerous linked glucose molecules, each of which exposes three hydroxyl groups. The Degree of Substitution (DS) of a given form of methyl cellulose is defined as the average number of substituted hydroxyl groups per glucose. The theoretical maximum is thus a DS of 3.0, however more typical values are 1.3 2.6. Methyl cellulose (or methylcellulose) is a chemical compound derived from cellulose. It is a hydrophilic white powder in pure form and dissolves in cold (but not in hot) water, forming a clear viscous solution or gel. It is sold under a variety of trade names and is used as a thickener and emulsifier in various food and cosmetic products, and also as a treatment of constipation. Like cellulose, it is not digestible, not toxic, and not allergenic A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AC - Bulk-forming laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative Stabiliser, thickener and emulsifier for foodstuffs
Ethyl cellulose
C20H38O11 (454.24139979999995)
Ethyl cellulose is a stabiliser and thickener for foods. Diluent in food marking inks. Indirect additive arising by migration from paper/paperboard packaging Ethyl cellulose is a derivative of cellulose in which some of the hydroxyl groups on the repeating glucose units are converted into ethyl ether groups. The number of ethyl groups can vary depending on the manufacture. Stabiliser and thickener for foods. Diluent in food marking inks. Indirect additive arising by migration from paper/paperboard packaging D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions D001697 - Biomedical and Dental Materials D002317 - Cardiovascular Agents
Lithocholic acid 3-sulfate
beta-Funaltrexamine
ribostamycin
alpha-Guttiferin
Constituent of Gamboge the resinous exudation of Garcinia morella (batuan). alpha-Guttiferin is found in herbs and spices and fruits.
Cardivin D
A germacranolide isolated from the aerial parts of Carpesium divaricatum. It exhibits cytotoxicity against the human tumor cells, A-549 (nonsmall cell lung), SK-OV-3 (ovary), SK-MEL-2 (skin), XF-498 (central nervous system) and HCT-15 (colon).
[3aR-[3aalpha,5(S*),7aalpha]]-5-[4-[(6-O-acetyl-beta-D-glucopyranosyl)oxy]-1-methylbutyl]-3a,4,7,7a-tetrahydro-6-methyl-3-methylene-2(3H)-benzofuranone
(10R)-3-heptyl-8-methoxy-10-pentyl-10,11-dihydro-2H,5H-furan[3,2-f]pyran[5,6-c][1]benzopyran-2,5-dione|fordianin A
(3xi,4R)-4-hydroxy-3-isopropylpentyl beta-rutinoside|(4R)-4-hydroxy-3-(1-methylethyl)pentyl rutinoside
C20H38O11 (454.24139979999995)
2,2,2,2-Tetramethyl-3,3,4,4-tetrahydro-5,5-bi[2H-naphtho[1,2-b]pyran]-6,6-diol
Me glycoside, 2-benzyl,3,4-O-isopropylidene-alphaalpha-Pyranose-2-O-alpha-L-Fucopyranosyl-L-fucose|Me glycoside, Benzyl glycoside,2-benzyl,3,4-O-isopropylidene-Alpha-Pyranose-2-O-alpha-L-Fucopyranosyl-L-fucose
Valeriandoid F
1-[3-(7-ethoxy-6-hydroxy-3,7-dimethyloct-2-enyl)-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
Val Ala His Glu
Tenovin-6
Tenovin-6, an analog of Tenovin-1 (HY-13423), is an activator of p53 transcriptional activity. Tenovin-6 inhibits the protein deacetylase activities of purified human SIRT1, SIRT2, and SIRT3 with IC50s of 21 μM, 10 μM, and 67 μM, respectively. Tenovin-6 also inhibits dihydroorotate dehydrogenase (DHODH)[1][2].
Ala Ala Phe Phe
Ala Asp His Ile
Ala Asp His Leu
Ala Asp Ile His
Ala Asp Leu His
Ala Glu His Val
Ala Glu Val His
Ala Phe Ala Phe
Ala Phe Phe Ala
Ala His Asp Ile
Ala His Asp Leu
Ala His Glu Val
Ala His Ile Asp
Ala His Leu Asp
Ala His Met Pro
Ala His Pro Met
Ala His Val Glu
Ala Ile Asp His
Ala Ile His Asp
Ala Leu Asp His
Ala Leu His Asp
Ala Met His Pro
Ala Met Pro His
Ala Pro His Met
Ala Pro Met His
Ala Thr Thr Tyr
Ala Thr Tyr Thr
Ala Val Glu His
Ala Val His Glu
Ala Tyr Thr Thr
Cys His Pro Val
Cys His Val Pro
Cys Pro His Val
Cys Pro Val His
Cys Val His Pro
Cys Val Pro His
Asp Ala His Ile
Asp Ala His Leu
Asp Ala Ile His
Asp Ala Leu His
Asp His Ala Ile
Asp His Ala Leu
Asp His Ile Ala
Asp His Leu Ala
Asp Ile Ala His
Asp Ile His Ala
Asp Leu Ala His
Asp Leu His Ala
Glu Ala His Val
Glu Ala Val His
Glu Gly His Ile
Glu Gly His Leu
Glu Gly Ile His
Glu Gly Leu His
Glu His Ala Val
Glu His Gly Ile
Glu His Gly Leu
Glu His Ile Gly
Glu His Leu Gly
Glu His Val Ala
Glu Ile Gly His
Glu Ile His Gly
Glu Ile Pro Pro
Glu Leu Gly His
Glu Leu His Gly
Glu Leu Pro Pro
Glu Pro Ile Pro
Glu Pro Leu Pro
Glu Pro Pro Ile
Glu Pro Pro Leu
Glu Val Ala His
Glu Val His Ala
Phe Ala Ala Phe
Phe Ala Phe Ala
Phe Phe Ala Ala
Phe Ser Thr Thr
Phe Thr Ser Thr
Phe Thr Thr Ser
Gly Glu His Ile
Gly Glu His Leu
Gly Glu Ile His
Gly Glu Leu His
Gly His Glu Ile
Gly His Glu Leu
Gly His Ile Glu
Gly His Lys Asn
Gly His Leu Glu
Gly His Asn Lys
Gly Ile Glu His
Gly Ile His Glu
Gly Lys His Asn
Gly Lys Asn His
Gly Leu Glu His
Gly Leu His Glu
Gly Asn His Lys
Gly Asn Lys His
His Ala Asp Ile
His Ala Asp Leu
His Ala Glu Val
His Ala Ile Asp
His Ala Leu Asp
His Ala Met Pro
His Ala Pro Met
His Ala Val Glu
His Cys Pro Val
His Cys Val Pro
His Asp Ala Ile
His Asp Ala Leu
His Asp Ile Ala
His Asp Leu Ala
His Glu Ala Val
His Glu Gly Ile
His Glu Gly Leu
His Glu Ile Gly
His Glu Leu Gly
His Glu Val Ala
His Gly Glu Ile
His Gly Glu Leu
His Gly Ile Glu
His Gly Lys Asn
His Gly Leu Glu
His Gly Asn Lys
His Ile Ala Asp
His Ile Asp Ala
His Ile Glu Gly
His Ile Gly Glu
His Lys Gly Asn
His Lys Asn Gly
His Leu Ala Asp
His Leu Asp Ala
His Leu Glu Gly
His Leu Gly Glu
His Met Ala Pro
His Met Pro Ala
His Asn Gly Lys
His Asn Lys Gly
His Pro Ala Met
His Pro Cys Val
His Pro Met Ala
His Pro Thr Thr
His Pro Val Cys
His Thr Pro Thr
His Thr Thr Pro
His Val Ala Glu
His Val Cys Pro
His Val Glu Ala
His Val Pro Cys
Ile Ala Asp His
Ile Ala His Asp
Ile Asp Ala His
Ile Asp His Ala
Ile Glu Gly His
Ile Glu His Gly
Ile Glu Pro Pro
Ile Gly Glu His
Ile Gly His Glu
Ile His Ala Asp
Ile His Asp Ala
Ile His Glu Gly
Ile His Gly Glu
Ile Pro Glu Pro
Ile Pro Pro Glu
Lys Gly His Asn
Lys Gly Asn His
Lys His Gly Asn
Lys His Asn Gly
Lys Asn Gly His
Lys Asn His Gly
Leu Ala Asp His
Leu Ala His Asp
Leu Asp Ala His
Leu Asp His Ala
Leu Glu Gly His
Leu Glu His Gly
Leu Glu Pro Pro
Leu Gly Glu His
Leu Gly His Glu
Leu His Ala Asp
Leu His Asp Ala
Leu His Glu Gly
Leu His Gly Glu
Leu Pro Glu Pro
Leu Pro Pro Glu
Met Ala His Pro
Met Ala Pro His
Met His Ala Pro
Met His Pro Ala
Met Pro Ala His
Met Pro His Ala
Asn Gly His Lys
Asn Gly Lys His
Asn His Gly Lys
Asn His Lys Gly
Asn Lys Gly His
Asn Lys His Gly
Asn Pro Pro Gln
Asn Pro Gln Pro
Asn Gln Pro Pro
Pro Ala His Met
Pro Ala Met His
Pro Cys His Val
Pro Cys Val His
Pro Glu Ile Pro
Pro Glu Leu Pro
Pro Glu Pro Ile
Pro Glu Pro Leu
Pro His Ala Met
Pro His Cys Val
Pro His Met Ala
Pro His Thr Thr
Pro His Val Cys
Pro Ile Glu Pro
Pro Ile Pro Glu
Pro Leu Glu Pro
Pro Leu Pro Glu
Pro Met Ala His
Pro Met His Ala
Pro Asn Pro Gln
Pro Asn Gln Pro
Pro Pro Glu Ile
Pro Pro Glu Leu
Pro Pro Ile Glu
Pro Pro Leu Glu
Pro Pro Asn Gln
Pro Pro Gln Asn
Pro Gln Asn Pro
Pro Gln Pro Asn
Pro Thr His Thr
Pro Thr Thr His
Pro Val Cys His
Pro Val His Cys
Gln Asn Pro Pro
Gln Pro Asn Pro
Gln Pro Pro Asn
Ser Phe Thr Thr
Ser Ser Val Tyr
Ser Ser Tyr Val
Ser Thr Phe Thr
Ser Thr Thr Phe
Ser Val Ser Tyr
Ser Val Tyr Ser
Ser Tyr Ser Val
Ser Tyr Val Ser
Thr Ala Thr Tyr
Thr Ala Tyr Thr
Thr Phe Ser Thr
Thr Phe Thr Ser
Thr His Pro Thr
Thr His Thr Pro
Thr His Val Val
Thr Pro His Thr
Thr Pro Thr His
Thr Ser Phe Thr
Thr Ser Thr Phe
Thr Thr Ala Tyr
Thr Thr Phe Ser
Thr Thr His Pro
Thr Thr Pro His
Thr Thr Ser Phe
Thr Thr Tyr Ala
Thr Val His Val
Thr Tyr Ala Thr
Thr Tyr Thr Ala
Val Ala Glu His
Val Cys His Pro
Val Cys Pro His
Val Glu Ala His
Val Glu His Ala
Val His Ala Glu
Val His Cys Pro
Val His Glu Ala
Val His Pro Cys
Val Pro Cys His
Val Pro His Cys
Val Ser Ser Tyr
Val Ser Tyr Ser
Val Tyr Ser Ser
Tyr Ala Thr Thr
Tyr Ser Ser Val
Tyr Ser Val Ser
Tyr Thr Ala Thr
Tyr Thr Thr Ala
Tyr Val Ser Ser
PG(14:1(9Z)/0:0)
C20H39O9P (454.23315740000004)
methyl cellulose
C20H38O11 (454.24139979999995)
A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AC - Bulk-forming laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative
Ethocel
C20H38O11 (454.24139979999995)
D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions D001697 - Biomedical and Dental Materials D002317 - Cardiovascular Agents
Butyl (S)-3-hydroxybutyrate [arabinosyl-(1->6)-glucoside]
C19H34O12 (454.20501640000003)
3-O-(alpha-L-arabinopyranosyl-(1->6)-beta-D-glucopyranosyl) butyl 3S-hydroxybutanoate
C19H34O12 (454.20501640000003)
3-O-(alpha-L-arabinopyranosyl-(1->6)-beta-D-glucopyranosyl) butyl 3R-hydroxybutanoate
C19H34O12 (454.20501640000003)
FA 19:2;O10
C19H34O12 (454.20501640000003)
1-(furan-2-yl)-3-[2-[[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]benzimidazol-1-yl]propan-1-one
C28H30N4O2 (454.23686399999997)
butane-1,4-diol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene,oxepan-2-one
Octimibate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
1,2-Dibenzyl 3-tert-butyl piperazine-1,2,3-tricarboxylate
siramesine
C30H31FN2O (454.24202879999996)
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene
N-Phenyl-5-(4-Fluorophenyl)-2-isopropyl-1-(3-oxopropyl)-4-phenyl-1H-pyrrole-3-carboxamide
4-[6-(Tributylstannyl)pyridin-2-yl]morpholine
C21H38N2OSn (454.20059679999997)
2-Morpholino-5-(tributylstannyl)pyridine
C21H38N2OSn (454.20059679999997)
TRIISOPROPYL((4-((4-((TRIMETHYLSILYL)ETHYNYL)PHENYL)ETHYNYL)PHENYL)ETHYNYL)SILANE
Biphenylindanone A
Biphenylindanone A (BINA) is a selective human mGluR2 (hmGluR2) potentiator for the treatment of many neurological disorders[1].
Octyl4-O-(b-D-galactopyranosyl)-b-D-glucopyranoside
C20H38O11 (454.24139979999995)
butane-1,4-diol,1-isocyanato-3-[(3-isocyanatophenyl)methyl]benzene,oxepan-2-one
4-methylumbelliferyl phosphate, bis(cyclohexylammonium) salt
C22H35N2O6P (454.22326200000003)
1,10-Decanedione,1,10-bis(1-hydroxy-2-naphthyl)- (6CI,8CI)
Lisuride Maleate
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists
2-(2-Methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl 4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinecarboxylate
Benzyl 3-isobutyrloxy-1-isopropyl-2,2-dimethylpropyl phthalate
Benzamide, 3-ethyl-4-[3-(1-methylethyl)-4-[4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl]-1H-pyrazolo[3,4-b]pyridin-1-yl]-
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
Ohcos
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)-N-[(1R,2R)-1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-1-hydroxy-3-methylbutan-2-yl]acetamide
2-[3,4-Dihydroxy-2-hydroxymethyl-5-(2-hydroxy-nonyl)-tetrahydro-furan-2-yloxy]-6-hydroxymethyl-tetra hydro-pyran-3,4,5-triol
C20H38O11 (454.24139979999995)
20-hydroxy-leukotriene E4(1-)
C23H36NO6S- (454.22632160000006)
Conjugate base of 20-hydroxy-leukotriene E4.
octyl 6-O-beta-D-galactofuranosyl-alpha-D-glucopyranoside
C20H38O11 (454.24139979999995)
A disaccharide derivative that is the octyl glycoside of the disaccharide beta-D-galactofuranosyl-(1->6)-alpha-D-glucose.
phosphono [(2E,7R,11S)-3,7,11,15-tetramethylhexadeca-2,14-dienyl] hydrogen phosphate
[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] tetradec-9-enoate
C20H39O9P (454.23315740000004)
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (E)-tetradec-11-enoate
C20H39O9P (454.23315740000004)
Methyl (E)-4-[[3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-4-oxobut-2-enoate
(3R,3aS,7R,7aS)-3-[4-[4-(dimethylamino)phenyl]-2-fluorophenyl]-7-methyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one
C30H31FN2O (454.24202879999996)
(3S,5aS,8aR,9aS)-7,7,8,8-tetramethyl-5a-nitrospiro[1,8-dihydropyrano[2,3-g]indole-3,7-2,3,4,5,6,8a,9,9a-octahydro-1H-cyclopenta[f]indolizin-4-ium]-2,9-dione
1-Arachidonoylglycerone 3-phosphate(2-)
C23H35O7P-2 (454.21202900000003)
6-ethyl-3-[[[1-(2-furanylmethyl)-5-tetrazolyl]methyl-(phenylmethyl)amino]methyl]-1H-quinolin-2-one
1-[(2-Methoxyphenyl)-[1-(2-phenylethyl)-5-tetrazolyl]methyl]-4-phenylpiperazine
5-tert-butyl-N-[5-(dimethylsulfamoyl)-2-methylphenyl]-2-(phenylmethyl)-3-pyrazolecarboxamide
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
N-[(6aS,8S)-2-(2,3-dimethylphenyl)-6,12-dioxo-5,6a,7,8,9,10-hexahydropyrido[2,1-c][1,4]benzodiazepin-8-yl]pyridine-3-carboxamide
1-O-caproyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine
A 1,2-diacyl-sn-glycero-3-phosphocholine having caproyl and 5-oxovaleryl groups at the 1- and 2-positions respectively.
N-benzyloxycarbonylaminoethyl-4,6-dideoxy-4-(3-hydroxy-3-methylbutanamido)-2-O-methyl-beta-D-glucopyranoside
[(1R)-7-methoxy-9-methyl-1-[[4-(2-pyridinyl)phenyl]methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C28H30N4O2 (454.23686399999997)
[(1S)-7-methoxy-9-methyl-1-[[4-(2-pyridinyl)phenyl]methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C28H30N4O2 (454.23686399999997)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxyacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxyacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
ethyl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(phenylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(2-methoxyphenyl)methyl]acetamide
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
ethyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1R)-1-phenylethyl]acetamide
2-[(1R,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
ethyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
C26H34N2O5 (454.24675940000003)
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2S,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
Octyl 6-O-[(4xi)-D-xylo-hexofuranosyl]-alpha-D-glucopyranoside
C20H38O11 (454.24139979999995)
(5E)-5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-(1H-pyridin-4-ylidene)-1H-imidazol-4-ylidene]-N-oxido-2,3-dihydroinden-1-amine
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tetradec-9-enoate
C20H39O9P (454.23315740000004)
alpha-D-Glucopyranoside, 2,3,4,6-tetra-O-methyl-alpha-D-glucopyranosyl 2,3,4,6-tetra-O-methyl-
C20H38O11 (454.24139979999995)
2,2,3,3,4,4,6,6-Octa-ortho-[D3]methyl-trehalose-D24
C20H38O11 (454.24139979999995)
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
(2S,3R,4S,5S,6S)-5-amino-2-(aminomethyl)-6-[(1S,2S,3R,4S,6R)-4,6-diamino-2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
ribostamycin
An amino cyclitol glycoside that is 4,6-diaminocyclohexane-1,2,3-triol having a 2,6-diamino-2,6-dideoxy-alpha-D-glucosyl residue attached at position 1 and a beta-D-ribosyl residue attached at position 2. It is an antibiotic produced by Streptomyces ribosidificus (formerly S. thermoflavus). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
beta-Funaltrexamine
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D009676 - Noxae > D000477 - Alkylating Agents
Ethyl cellulose
C20H38O11 (454.24139979999995)
D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions D001697 - Biomedical and Dental Materials D002317 - Cardiovascular Agents
1-Arachidonoylglycerone 3-phosphate(2-)
C23H35O7P (454.21202900000003)
A 1-acylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-arachidonoylglycerone 3-phosphate; major species at pH 7.3.
1-(9Z-tetradecenoyl)-glycero-3-phospho-(1-sn-glycerol)
C20H39O9P (454.23315740000004)
AZD9056 (hydrochloride)
AZD9056 hydrochloride is a selective orally active inhibitor of P2X7 which plays a significant role in inflammation and pain-causing diseases.
8-(benzoyloxy)-6-(hydroxymethyl)-2,13-dimethyl-12-oxotetracyclo[11.2.1.0¹,¹⁰.0²,⁷]hexadecane-6-carboxylic acid
7a,9-dihydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,9,10,11,11b,12-hexahydro-6h-2,5-dioxatetraphen-1-one
5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-ol
C26H34N2O5 (454.24675940000003)
2-{7-[6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-4-methylhept-3-en-1-yl}-2,6-dimethylchromene-5,8-dione
(1r,9s,10s,12s,13e,15s,16s,17r,18s)-18-(acetyloxy)-13-ethylidene-4-methoxy-17-(methoxycarbonyl)-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-15-ium-15-olate
5-heptyl-12-methoxy-15-pentyl-3,9,14-trioxatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-1(10),2(7),5,11,13(17)-pentaene-4,8-dione
2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{2-[2-(2-hydroxypropan-2-yl)-3-methyloxiran-2-yl]ethoxy}oxane-3,4,5-triol
C19H34O12 (454.20501640000003)